CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience / Bomben, R.; Zucchetto, A.; Laureana, R.; Chiarenza, A.; Olivieri, J.; Tissino, E.; Rossi, F. M.; Vit, F.; Bittolo, T.; Papotti, R.; Pozzo, F.; Gaglio, A.; Degan, M.; Polesel, J.; Marasca, R.; Visentin, A.; Moia, R.; Innocenti, I.; Vitale, C.; Murru, R.; Varettoni, M.; Tafuri, A.; Zaja, F.; Postorino, M.; Martino, E. A.; Condoluci, A.; Rossi, D.; Cuneo, A.; Di Raimondo, F.; Sportoletti, P.; Del Giudice, I.; Foà, R.; Mauro, F. R.; Coscia, M.; Laurenti, L.; Gaidano, G.; Trentin, L.; Principe, M. I. D.; Gentile, M.; Gattei, V.. - In: HEMASPHERE. - ISSN 2572-9241. - 8:7(2024), pp. 1-5. [10.1002/hem3.128]